Status:
COMPLETED
Aztreonam for Pharyngeal Gonorrhea
Lead Sponsor:
University of Washington
Conditions:
Gonorrhea of Pharynx
Gonorrhea
Eligibility:
All Genders
16+ years
Phase:
PHASE2
PHASE3
Brief Summary
The Centers for Disease Control and Prevention has identified antimicrobial-resistant (AMR) Neisseria gonorrhoeae (NG) as one of the nation's top three urgent AMR threats. Since the advent of antibiot...
Eligibility Criteria
Inclusion
- Persons diagnosed with pharyngeal gonorrhea or gonococcal urethritis who are undergoing pharyngeal gonorrhea testing, who are not yet treated.
Exclusion
- Age less than 16 years
- Receipt of antibiotics in ≤30 days
- Known allergy to aztreonam
- History of renal disease (including diagnosis of solitary kidney, chronic renal insufficiency, renal cell carcinoma etc.)
- Concurrent infection with syphilis or chlamydia
- Pregnancy and/or nursing
- Unable to return for a follow-up visit 4-7 days (+/- 1 day).
- Study team's discretion
Key Trial Info
Start Date :
April 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT03867734
Start Date
April 5 2019
End Date
September 30 2019
Last Update
January 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Public Health -- Seattle & King County STD Clinic
Seattle, Washington, United States, 98104